Obagi C-Therapy Night Cream
Testo originale in francese.
Prodotto naturale per la salute autorizzato in Canada
L’analisi delle dosi orali non si applica senza una via esclusivamente orale accertata.
Composizione
| Ingrediente medicinale e fonte | Per unità posologica, secondo la fonte |
|---|---|
| 1,4-Benzènediol Fonte : Hydroquinone | 4,16 % |
Ingredienti non medicinali
Parahydroxybenzoate de méthyle, Saponins, Alcool cétylique, Phényl triméthicone, Métabisulfite de sodium, (p)-hydroxybenzoate de propyle, Glycérine, Eau purifiée, Acétate de dl-alpha tocophéryle, PPG-2-Myristyl Ether Propionate, Edetate Disodium, Vitamine C, BHT, Laureth sulfate de sodium
Dosi raccomandate in Canada
| Popolazione | Età | Quantità per assunzione | Frequenza |
|---|---|---|---|
| Adultes | Non précisée | Non précisée | Non précisée |
Usi autorizzati in Canada
For the gradual lightening of hyperpigmented skin conditions.
Testo originale in inglese.
Un uso autorizzato in Canada non è un’indicazione sulla salute autorizzata nell’Unione europea. Consulti il registro delle indicazioni sulla salute.
Avvertenze in Canada
Contra-Indications : People with prior history of sensitivity or allergic reactions to this product or any of its ingredients should not use the products. If you have a family history of, have or have had, or are at risk of developing cancer, do not use. The safety of topical hydroquinone use during pregnancy or in children (12 years and under) has not been established. Not for use on children under 12 years of age. Do not use this product if you are nursing, pregnant or if you intend to become pregnant within three months of use.
Testo originale in inglese.
Known Adverse Reactions : No systemic adverse reactions have been reported. Discontinue use in case of irritation, rash, excessive inflammatory response or if a gradual blue-black darkening of the skin (exogenous ochronosis) occurs. Minor redness is acceptable, but where there is excessive irritation, a rash or other reaction, further treatment is not advised. Severe itching or reddening may occur, in which the product should be discontinued and the physician notified immediately. Contains sodium metabisulfate, a sulfate that may cause serious allergic type reactions (e.g., hives, itching, wheezing, anaphylaxis, severe asthma attacks) in certain susceptible persons.
Testo originale in inglese.
Cautions and Warnings : To be used only on the advice of a physician. Use only as directed. Apply only to small skin surface areas. Do not apply over sunburn or irritated skin. A mild transient stinging or minor redness may occur in people with sensitive skin. Discontinue use and consult a physician in case of skin reactions or a blue-black darkening of the skin. Hydroquinone is a skin bleaching agent which may produce unwanted cosmetic effects if not used as directed. Treatment should be limited to relatively small areas of the body at one time. Sunscreen use is an essential aspect of hydroquinone therapy because even minimal sunlight exposure may cause skin re-darkening. Limit sun exposure and apply a sunburn protectant while using this product and for a week afterwards. For external use only. Do not use near eyes, mucous membranes, or on broken or irritated skin. In case of contact, rinse thoroughly with water. In case of accidental ingestion, seek medical assistance or contact a Poison Control Center immediately. A bitter taste and anesthetic effect may occur if applied to lips. Test for skin sensitivity. To test for sensitivity apply to an area of approximately 1 cm2 of unbroken skin on the inside of the arm. If no irritation occurs within 24 hours, begin treatment for up to 12 weeks. Keep out of reach of children. Note: slight darkening of the product is normal and does not affect its potency. The physician should be familiar with the contents of this insert before prescribing of dispensing this product. Close patient supervision is recommended.
Testo originale in inglese.
Scheda del prodotto
- Titolare
- Obagi Medical Products, a division of Valeant Pharmaceuticals North America LLC.
- NPN o DIN-HM
- 80040470
- Stato
- Licenza non attiva
- Data della licenza
- 28 febbraio 2013
- Data di revisione
- 7 marzo 2014
- Forma
- Crème
- Via di somministrazione
- Topique
- Tipo di domanda
- Non traditionnelle
Fonte
Scheda ufficiale Health Canada, licenza 80040470
Banca dati dei prodotti naturali per la salute autorizzati (BDPSNH), Health Canada: prodotti autorizzati, ingredienti, dosi, usi e avvertenze, consultato il 27 ottobre 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Testo originale in inglese.
Testo originale in francese.
La formula venduta in Europa con lo stesso nome può essere diversa. Queste informazioni non sostituiscono il parere di un medico o farmacista.
Elenco nella revisione ufficiale del (registro: Banca dati dei prodotti naturali per la salute autorizzati (BDPSNH), Health Canada: prodotti autorizzati, ingredienti, dosi, usi e avvertenze).
Un'informazione inesatta o più recente su questo prodotto, che lei sia lettore o marca? Scriva a contact@compoatlas.com: ogni correzione è pubblicata nel registro delle correzioni.